Neoleukin Therapeutics (NLTX) Investor Presentation - Slideshow

neoleukin" THERAPEUTICS De novo proteins for immunotherapy ̸ January 2020 Forward Looking Statements Certain of the statements made in these slides and the accompanying oral presentation are forward looking, including those relating to Neoleukin's business, strategy, future operations, advancement of its product candidates and product pipeline, clinical development of its product candidates, including expectations regarding timing of regulatory submissions and initiation of clinical trials, regulatory requi ...